星空游戏网站免费进入|星空彩票电脑版

摘要/Abstract

摘要：

肾上腺髓质素（adrenomedullin，ADM）是一种舒血管活性多肽物质，共由52 个氨基酸组成，其主要特点为第16 位与21 位半胱氨酸残基间由二硫键连接。它在心、肺等重要器官中具有高水平表达，其合成、分泌的主要部位为血管内皮细胞和平滑肌细胞，其中内皮细胞占主导地位。ADM 具有舒张血管、降压、利尿、抗炎、参与氧化应激、抑制平滑肌细胞增殖、迁移、分化等多种作用，在心肺相关性疾病中具有诸多研究，该文综述了ADM 在心、肺相关性疾病中的研究进展，以期为临床治疗提供新思路。

关键词:肾上腺髓质素,心肺疾病,研究进展

Abstract:

Adrenomedullin （ADM） is a vasodilator active polypeptide consisting of 2 amino acids. Its main characteristic is that the 16th and 21st cysteine residues are linked y disulfide bonds. It is highly expressed in heart，lung and other important organs. The main arts of synthesis and secretion are vascular endothelial cells and smooth muscle cells，in which ndothelial cells play a dominant role. It has many functions，such as vasodilation，hypotension， iuresis，anti-inflammation，participation in oxidative stress，inhibition of smooth muscle cell roliferation，migration and differentiation，etc. It has many studies in cardiopulmonary-related iseases. This article reviews the research progress of ADM in cardiopulmonary-related diseases， n order to provide new ideas for clinical treatment.

中图分类号:

R966

郭沫然，周城伟，张志华.肾上腺髓质素在心、肺相关性疾病中的研究进展[J]. 神经药理学报,DOI: 10.3969/j.issn.2095-1396.2019.01.006.

GUO Mo-ran，ZHOU Cheng-wei，ZHANG Zhi-hua.Progress of Adrenomedullin in Cardiopulmonary Related Diseases[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2019.01.006.

参考文献

[1]Kenji Kuwasako, Kazuo Kitamura, Sayaka Nagata, et al. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization[J]. Biochem Biophys Res Commun, 2012, 420(3):582-587.
[2] David M Smith, Coppock H A, Dominic J Withers, et al. Adrenomedullin: receptor and signal transduction[J]. Biochem Soc, 2002, 30(4):432-437.
[3]Erkan Yildirim, Mahir Cengiz, Nilgun Yidirim, et al. The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure[J]. Anatol J Cardiol, 2014, 17(3):184-190.
[4] M Randa Abedl Kader, Grace B D M, Nora Badawi. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies[J]. Ital J Biochem, 2007, 56(1):18-27.
[5] Qiao Xi, Li Rong-shan, Li Hong, et al. Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress[J]. Am J Physiol Renal Physiol, 2013, 304(1):F112-F119.
[6]阳明玉,秦静廷,王丹,等.肾上腺髓质素在先天性心脏病患儿合并心力衰竭时的变化及意义[J].实用医学杂志,2017,33(21):3647-3649.
[7]马小风,高海英.肾上腺髓质素对评价小儿急性心力衰竭治疗及预后的临床价值探讨[J].国际检验医学杂志,2014,35(24):3369-3370.
[8]阳明玉,王丹,宋晓丹,等.先天性心脏病患儿手术前后血浆肾上腺髓质素的变化[J].华夏医学,2016,29(6):18-21.
[9] St John Sutton M, Pfeffer M A, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial[J].Circulation, 1997, 96(10):3294-3299.
[10]郭继鸿，胡大一，蒋文平，等.中国心律学—2010[M].北京：人民卫生出版社，2010:66.
[11]王月红,王丽,李诗洋.血浆脑钠肽与肾上腺髓质素水平在慢性心率增快心力衰竭患者中的临床意义[J].当代医学,2016,22(20):10-12.
[12] Chun T H, Hiroshi Itoh, Takatoshi Saito, et al. Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin[J]. J Hypertens, 2000, 18(5):575-580.
[13]周蔓娟.原发性高血压患者血浆中肾上腺髓质素、C-反应蛋白变化探讨[J].心血管病防治知识:学术版,2015(8):41-42.
[14] 李华,孙永新,孙叶飞,等.有氧运动对单纯舒张期高血压患者血压及血管活性介质的疗效[J].心血管康复医学杂志,2016,25(2):122-126.
[15] 许德英,常永超,程国平,等.妊娠高血压综合征患者血凝四项指标分析[J].中国实用医刊, 2009, 36(22):29-30.
[16] Ina Knerr, Cornelia Dachert, Ernst Beinder, et al. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreasedplacental mRNA content in preeclampsia and HELLP syndrome [J]. Eur J Obstet Gynecol Reprod Biol, 2002, 101(1):47-53.
[17] 黄意娟,张月红,叶赛芳.肾上腺髓质素和内皮素-1在妊娠高血压综合征患者血清中的表达[J].中国妇幼保健,2012,27(29):4531-4533.
[18] 黄彦霞,田慧敏,张曦,等.妊娠高血压综合征患者血浆ADM检测的临床意义[J].中外医疗,2012,31(22):178-179.
[19] Mariko Harada-Shiba, Itaru Takamisawa, Kanjiro Miyata, et al. Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats[J]. Mol Ther, 2009, 17(7):1180-1186.
[20] 王晓林,王庸晋,荣书玲,等.肾上腺髓质素对肺动脉高压大鼠血流动力学及细胞因子的影响[J].军事医学,2013,37(12):887-891.
[21] Noritoshi Nagaya, Shingo Kyotani, Masaaki Uematsu, et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension[J]. Circulation, 2004, 109(3):351-356.
[22] 刘丽平,庞璐璐,齐建光,等.肾上腺髓质素对高肺血流大鼠肺组织氧化应激的调节作用[J].中国病理生理杂志,2017,33(4):735-739.
[23] 秦静廷,阳明玉,王丹,等.先天性心脏病患儿血浆肾上腺髓质素与肺动脉高压的关系[J].岭南心血管病杂志,2017,23(2):191-193.
[24] Shixia H, Veronica M, Justin M. Extracellular Ca2+ stimulates the activationg of mitogen-activated protein kinase and cell growth in human fibroblast[J]. Biochem J, 1995, 310(Pt 3): 881-885.
[25] 郝淑玲,于忠和,齐保申,等.肾上腺髓质素对低氧时肺成纤维细胞内钙离子动态变化的影响[J].中国组织化学与细胞化学杂志,2012,21(3):214-217.
[26] Alan Fine, Ronald H Goldstein. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts[J]. J Biol Chem, 1987, 262(8):3897-3902.
[27] Li Rong-hui, Liang Jia-liang, Ni Su, et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts[J]. Cell Stem Cell, 2010, 7(1):64-77.
[28] 郝淑玲,王卫平,李建东,等.肾上腺髓质素和转化生长因子β_1对肺成纤维细胞增殖及c-myc表达的影响[J].中华实用诊断与治疗杂志,2015,29(4):333-335.
[29] Rosanna Di Paola, Elena Talero, Maria Galuppo, et al. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis[J]. Respir Res, 2011, 12(1):41.
[30] Carlos G Ramos, Sun Xi, Eric B Johnson, et al. Adrenomedullin expression in the developing human fetal lung[J]. J Investig Med, 2014, 62(1):49-55.
[31] 汪群智,盛美玲,宋昱晨,等.血清GRO-α水平和MRpro-ADM水平预测稳定期慢性阻塞性肺疾病患者急性加重和死亡风险的意义研究[J].中国全科医学,2017,20(18):2188-2192.
[32]苏宪灵, 齐菲, 解立新. 慢性阻塞性肺疾病患者血浆肾上腺髓质素水平的变化[J].蚌埠医学院学报, 2015, 40(7):857-858.
[33] Silvia Angeletti, Massimo Ciccozzi, Marta Fogolari, et al. Procalcitonin and MR-proAdrenomedullin combined score in the diagnosis and prognosis of systemic and localized bacterial infections[J]. J Infect, 2016, 72(3):395-398.
[34] Silvia Angeletti, Fabrizio Battistoni, Marta Fioravanti, et al. Procalcitonin and mid-regional, pro-adrenomedullin test combination, in sepsis diagnosis[J]. Clin Chem Lab Med, 2013, 51(5):1059-1067.
[35]王彦锋,白洁,李光明,等.血清降钙素原与肾上腺髓质素前体中段肽在婴幼儿细菌性肺炎诊疗中的临床研究[J].天津医科大学学报,2017,23(4):314-319.
[36] Iolanda Jordan, Patricia Corniero Alonso, M Balaguer Gargallo, et al. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children[J]. Biomark Med, 2014, 8(9):1065-1072.
[37] 胡铭,冯培峰,刘波,等.pro-AVP和pro-ADM对社区获得性肺炎严重度及预后的预测价值[J].热带医学杂志,2012,12(11):1353-1356.
[38] Caroline Courtais, Nils Kuster, Anne-Marie Dupuy, et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia[J]. Am J Emerg Med, 2013, 31(1):215-221.
[39] Jean-Laurent Deville, Sebastien Salas, Dominique Figarella-Branger, et al. Adrenomedullin as a therapeutic target in angiogenesis[J]. Expert Opin Ther Targets, 2010, 14(10):1059-1072.
[40] L Houcine Ouafik, Caroline Berenguer-Daize, Yolande Berthois. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway[J]. Cell Signal, 2009, 21(4):597-608.
[41] 黄志汉.康莱特注射液对非小细胞肺癌患者生活质量的影响及与ADM含量的相关性[J].中医临床研究,2017,9(5):24-26.
[42] 张隽, 孙培宗, 欧阳松云. 支气管哮喘患者血浆肾上腺髓质素的质量浓度及临床意义[J].中国实用内科杂志, 2003, 23(6):341-342.
[43]孙芳, 张曼林, 汤兵祥. 血浆肾上腺髓质素水平与哮喘的临床意义[J]. 中国医师进修杂志, 2004, 27(9):35-35.

肾上腺髓质素在心、肺相关性疾病中的研究进展

Progress of Adrenomedullin in Cardiopulmonary Related Diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章13

编辑推荐

Metrics

[1]	张冉冉, 张春月, 吴志刚.GABA_A受体与中枢神经系统疾病研究进展[J]. 神经药理学报, 2024, 14(6): 50-.
[2]	袁鑫茹, 张丹参.姜黄素纳米制剂研究进展[J]. 神经药理学报, 2024, 14(2): 54-.
[3]	姚鹏程, 马斌祥, 关永林, 李振豪, 常斌, 张思源.自体富血小板血浆治疗骨科损伤相关疾病的临床应用[J]. 神经药理学报, 2023, 13(2): 59-.
[4]	孙婷, 谢佳佳, 张丹参. 线粒体通透性转换孔在脑缺血再灌注损伤中的研究进展[J]. 神经药理学报, 2021, 11(2): 26-31.
[5]	张健美, 张丹参.溃疡性结肠炎中西治疗的研究进展[J]. 神经药理学报, 2020, 10(5): 43-47.
[6]	张浩楠, 杨辉.天然药物对脑缺血再灌注损伤保护作用的研究进展[J]. 神经药理学报, 2020, 10(4): 14-20.
[7]	金姗, 张丹参.利多卡因透皮制剂的研究进展[J]. 神经药理学报, 2020, 10(3): 16-20.
[8]	边芳，侯艳宁.ATP 敏感钾通道在神经退行性疾病中的研究进展[J]. 神经药理学报, 2017, 7(5): 52-58.
[9]	孙争宇，李林*.精神分裂症认知障碍研究进展[J]. 神经药理学报, 2017, 7(3): 60-60.
[10]	张海威，张力.乔松素临床应用和作用机制的研究进展[J]. 神经药理学报, 2016, 6(5): 45-52.
[11]	秦雪晴，杨志宏，孙晓波.血脑屏障体外模型的研究进展[J]. 神经药理学报, 2016, 6(1): 25-34.
[12]	王莹莹, 宋修云, 王奇, 陈乃宏.天然抗氧化剂在阿尔兹海默病中的应用研究进展[J]. 神经药理学报, 2015, 5(6): 30-34.
[13]	郭敏, 李刚.突触可塑性相关蛋白的研究进展[J]. 神经药理学报, 2013, 3(6): 57-64.